Adhera Therapeutics, Inc.

Industry

  • Biotechnology
    • Antisense, Oligonucleotides
  • Pharmaceuticals
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • Cequent Pharmaceuticals
  • IthenaPharma Inc.
  • Marina Biotech, Inc.
  • MDRNA, Inc.
  • Nastech Pharmaceutical Company Inc.
See more in Biomedtracker

Latest on Adhera Therapeutics, Inc.

Scrip

Deal Watch: Vanda Buys US, Canadian Rights To J&J’s Ponvory

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Vanda To Pay $100m For Rights To MS The

Scrip

Deal Watch: AbbVie To Try Caraway’s Lysosomal Function Approach To Parkinson’s

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie, Caraway Research Targets TMEM17

In Vivo

Deals Shaping The Medical Industry, July 2017

 
• By Beth Allan, Deanna Kamienski, Maureen Riordan, Steven Muntner, and Amanda Micklus

IN VITRO DIAGNOSTICS Mergers & Acquisitions PerkinElmer Inc. EuroImmun AG PerkinElmer Inc. acquired private German company EuroImmun AG (autoimmune, infectious disease, and allergy testing) fo

In Vivo

Execs On The Move, July 2016

 
• By Regina Paleski

Company Changes BENSON , Trey To: XBiotech Inc. , VP, Commercial Dev. & Mktg. (June) From: Edgemont Pharmaceuticals, VP, Mktg. Phone: 512-386-2900 BISHOP , John E. To: Genocea Biosciences I